Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Ann Surg Oncol
    May 2026
  1. ALTAF A, Akabane M, Tong K, Khalil M, et al
    Interplay of Tumor Morphology and Biology with Postoperative Complications: Prognostic Implications After Resection of Colorectal Liver Metastasis.
    Ann Surg Oncol. 2026;33:3930-3942.
    >> Share

  2. SWILLING AC, Chalise P, Al-Kasspooles M, Martin B, et al
    Volume-Outcome Relationships in Total Mesorectal Excision Quality and Grading: A National Cancer Database Study.
    Ann Surg Oncol. 2026;33:3806-3813.
    >> Share

  3. MORITA S, Okabayashi K, Endo Y, Kurebayashi Y, et al
    Background Liver Fibrosis as a Microenvironmental Risk Factor for Intrahepatic Recurrence in Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:3899-3909.
    >> Share

  4. HARTLEY BW, Chen VW, Amin P, Iqbal A, et al
    Shifting Paradigm: Utilization and Outcomes with Neoadjuvant Chemotherapy for cT4 and cN2 Colon Cancers.
    Ann Surg Oncol. 2026;33:3849-3860.
    >> Share

  5. VANDE KERCKHOVE FEC, Creemers DMJ, Banken E, Ketelaers SHJ, et al
    Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumour Characteristics.
    Ann Surg Oncol. 2026;33:3836-3848.
    >> Share

  6. ALLIEVI N, Bayney S, Samuel MV, Tzivanakis A, et al
    Raised Serum Tumour Markers Predict Incomplete Cytoreduction, Disease-Free and Overall Survival in Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and HIPEC.
    Ann Surg Oncol. 2026;33:4153-4160.
    >> Share

  7. CHANDRA P, Song Y, Seier K, Gonen M, et al
    The Effect of Pathologic Response to Preoperative Therapy on Margin Status and Outcomes After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:3875-3885.
    >> Share

  8. PROCOPIO F, Memeo R, Del Fabbro D, Abdelhadi S, et al
    Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis.
    Ann Surg Oncol. 2026;33:3886-3898.
    >> Share

  9. ZHANG T, Shi L, Jian L, Jiang J, et al
    Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial.
    Ann Surg Oncol. 2026;33:3814-3826.
    >> Share

    April 2026
  10. RADEMAKER E, Aktas BC, van den Berg R, Dekker JWT, et al
    The Impact of Postoperative Complications After Colon Cancer Surgery on Locoregional Recurrence: A Population-Based Dutch Cohort Study.
    Ann Surg Oncol. 2026 Apr 22. doi: 10.1245/s10434-026-19637.
    >> Share

  11. TURRI G, Pedrazzani C, Ruben S, Barresi V, et al
    The Prognostic Role of Postoperative Inflammation After Minimally Invasive Resection for Colorectal Cancer.
    Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19673.
    >> Share

  12. SMITH HG, Henriksen TV, Andersen CL
    ASO Author Reflections: Potential of Circulating Tumor DNA in Stratifying Patients with Localized pMMR Colon Cancer to Neoadjuvant Therapy.
    Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19682.
    >> Share

  13. MARTINEZ AE, DiBrito S
    ASO Author Reflections: Nationwide Disparities in Surgical Care of Colorectal Cancer Liver Metastases Persist Despite Advances in Liver-Directed Therapy.
    Ann Surg Oncol. 2026 Apr 16. doi: 10.1245/s10434-026-19636.
    >> Share

  14. SHIN JK, Kim HC, Lee WY, Yun SH, et al
    Calibrated Absolute Risk of Lymph-Node-Metastasis After Non-curative Endoscopic Resection of pT1 Colorectal Cancer.
    Ann Surg Oncol. 2026 Apr 13. doi: 10.1245/s10434-026-19582.
    >> Share

  15. CHINEN Y, Hata T, Takeda M, Sekido Y, et al
    ASO Visual Abstract: Clinical Significance of Bromodomain Containing Protein 9 in Colorectal Cancer.
    Ann Surg Oncol. 2026 Apr 8. doi: 10.1245/s10434-026-19524.
    >> Share

  16. MARTINEZ AE, Webber A, Davis L, Nigam A, et al
    ASO Visual Abstract: Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19603.
    >> Share

  17. SMITH HG, Henriksen TV, Andersen CL
    Potential of Circulating Tumor DNA in Stratifying Patients with Localized pMMR Colon Cancer to Neoadjuvant Therapy.
    Ann Surg Oncol. 2026 Apr 3. doi: 10.1245/s10434-026-19539.
    >> Share

  18. VAN DEN HEUVEL TBM, Rauwerdink P, Hulshof E, van de Vlasakker VCJ, et al
    Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II Trial.
    Ann Surg Oncol. 2026;33:3004-3017.
    >> Share

  19. BOYSEN M, Lai SH, Byers S, Widmar M, et al
    Rectal Cancer Watch-and-Wait Management of Patients With Tumors Within Versus Beyond the Reach of Digital Rectal Examination.
    Ann Surg Oncol. 2026;33:2856-2864.
    >> Share

  20. FOLKERT IW, Mehran R, Sun R, Morris VK, et al
    Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial.
    Ann Surg Oncol. 2026;33:2899-2907.
    >> Share

    March 2026
  21. GUPTA P, Godfrey EL, Schultz KS, Qiao L, et al
    ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2026 Mar 28. doi: 10.1245/s10434-026-19312.
    >> Share

  22. CHOUBEY AP, Seier K, Schleimer L, Barekzai AB, et al
    Hepatic Artery Infusion Pump Chemotherapy Associated Biliary Sclerosis After Treatment for Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2026 Mar 23. doi: 10.1245/s10434-026-19505.
    >> Share

  23. MARTINEZ AE, Webber A, Davis L, Nigam A, et al
    Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2026 Mar 14. doi: 10.1245/s10434-026-19483.
    >> Share

  24. VALDES N, Diaz L, Torrico P, Crespo I, et al
    Targeted Preoperative Nutritional Support within an Enhanced Recovery After Surgery Program for Malnourished Colorectal Cancer Patients: Postoperative Outcomes Comparable to Well-Nourished Patients in a Prospective Single-Center Cohort.
    Ann Surg Oncol. 2026 Mar 13. doi: 10.1245/s10434-025-18778.
    >> Share

  25. CHINEN Y, Hata T, Takeda M, Sekido Y, et al
    Clinical Significance of Bromodomain-Containing Protein 9 in Colorectal Cancer.
    Ann Surg Oncol. 2026 Mar 12. doi: 10.1245/s10434-026-19336.
    >> Share

  26. HOPPING E, Gauci E, Brown K, Bhimani N, et al
    ASO Visual Abstract: Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.
    Ann Surg Oncol. 2026 Mar 2. doi: 10.1245/s10434-026-19164.
    >> Share

  27. MOROCHO B, Lightfoot S, Somasundar P, Kwon S, et al
    ASO Visual Abstract: Trends and Outcomes of Liver-First Surgical Approach in Patients with Colorectal Cancer and Isolated Liver Metastases.
    Ann Surg Oncol. 2026 Mar 2. doi: 10.1245/s10434-026-19320.
    >> Share

  28. NEBBIA M, Villard C, Gilg S, Sparrelid E, et al
    Sex-Associated Aspects of Referral, Resectability, and Survival in Patients with Colorectal Liver Metastases (CRLM): A Population-Based Single-Center Study of 1207 MDT-Referred Patients.
    Ann Surg Oncol. 2026;33:2527-2538.
    >> Share

  29. NAKAMURA K, Hayami S, Miyamoto A, Hirai Y, et al
    Thoracoscopic Liver Resection Combined with Laparoscopic Pringle Maneuver for Recurrent Tumor with Diaphragmatic Invasion and Intra-Abdominal Adhesions.
    Ann Surg Oncol. 2026;33:2553-2554.
    >> Share

  30. STEVANATO FILHO PR, Bezerra TS, Marques TMDM, Takahashi RM, et al
    Robotic Intracorporeal Single-Stapled Anastomosis (RISS) is Associated with Lower Anastomotic Leakage Rates than the Double-Stapled Technique After Minimally Invasive Total Mesorectal Excision for Rectal Cancer.
    Ann Surg Oncol. 2026;33:1935-1945.
    >> Share

  31. HILTY CHU BK, Dhimal T, Boyer M, Loria A, et al
    A Clinical Primer for Defining Time Zero in Rectal Cancer Studies of Nonoperative Management: Implications for Survival and Local Regrowth.
    Ann Surg Oncol. 2026;33:1927-1934.
    >> Share

  32. BIRGIN E, Rahbari NN
    Continuous Robotic Ultrasound Hepatectomy (CRUSH): A Novel Approach for Parenchyma-Sparing Liver Surgery.
    Ann Surg Oncol. 2026;33:2551-2552.
    >> Share

    February 2026
  33. GUPTA P, Godfrey EL, Schultz KS, Qiao L, et al
    ASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19269.
    >> Share

  34. SASSUN R, Larson DW, Sileo A, Sabella G, et al
    ASO Visual Abstract: Do Tumor Deposits Demand More? Association of Chemotherapy Regimen Intensity with Survival Outcomes in N1 Colon Cancer Patients with Tumor Deposits.
    Ann Surg Oncol. 2026 Feb 20. doi: 10.1245/s10434-026-19293.
    >> Share

  35. SASSUN R, Sileo A, Brucchi F
    ASO Author Reflections: Tumor Deposits in Colon Cancer: A Plea to Tailor Chemotherapy Regimens in N1 Patients.
    Ann Surg Oncol. 2026 Feb 7. doi: 10.1245/s10434-026-19247.
    >> Share

  36. MOROCHO B, Lightfoot S, Somasundar P, Kwon S, et al
    Trends and Outcomes of the Liver-First Surgical Approach for Patients with Colorectal Cancer and Isolated Liver Metastases.
    Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-026-19180.
    >> Share

  37. GUPTA P, Godfrey EL, Schultz KS, Qiao L, et al
    Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-025-19057.
    >> Share

  38. HU Z, Tan K, Hu K, Xiao G, et al
    Non-steroidal Anti-inflammatory Drugs and Timing-specific Anastomotic Leak Risk Following Minimally Invasive Proctectomy: A Retrospective Cohort Study.
    Ann Surg Oncol. 2026;33:1270-1278.
    >> Share

  39. CAI Z, Bai F, Liu X, Wang Z, et al
    Prognostic Value of Pathological Risk Parameters in Predicting Postrecurrent Survival for Locally Recurrent Rectal Cancer Patients Undergoing Salvage Radical Surgery: Result from a Median 5-year Follow-Up Study.
    Ann Surg Oncol. 2026;33:1260-1269.
    >> Share

  40. CATS M, Magermans LG, Wassenaar ECE, van Geloven AAW, et al
    The Clinical Presentation of Anastomotic Leakage Compared Between CRS-HIPEC and Conventional Colorectal Surgery.
    Ann Surg Oncol. 2026;33:1706-1715.
    >> Share

  41. MAINA C, Lopez-Lopez V, Ratti F, Santangelo D, et al
    Hepatic Hypertrophy Techniques: Comparing Perioperative Outcomes of Liver Venous Deprivation (LVD) and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy-Variants (vALPPS) Among Two Referral Centers.
    Ann Surg Oncol. 2026;33:1503-1514.
    >> Share

  42. ZAKI OA, Narayan RR, Srouji R, Boerner T, et al
    Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:1490-1502.
    >> Share

  43. SAADAT LV, Goldman DA, Kalvin H, Gonen M, et al
    One-Year Mortality after Hepatectomy: Defining a Novel Quality Metric.
    Ann Surg Oncol. 2026;33:1481-1489.
    >> Share

  44. BOILEVE A, Audemar F, Dupont-Bierre E, Le Sourd S, et al
    Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Pha
    Ann Surg Oncol. 2026;33:1460-1469.
    >> Share

  45. LI J, Waller G, Qin Y, Yu AT, et al
    Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:1448-1459.
    >> Share

    January 2026
  46. HOPPING E, Gauci E, Brown K, Bhimani N, et al
    Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.
    Ann Surg Oncol. 2026 Jan 22. doi: 10.1245/s10434-025-18934.
    >> Share

  47. SASSUN R, Larson DW, Sileo A, Sabella G, et al
    Do Tumor Deposits Demand More? Association of Chemotherapy Regimen Intensity with Survival Outcomes in N1 Colon Cancer Patients with Tumor Deposits.
    Ann Surg Oncol. 2026 Jan 21. doi: 10.1245/s10434-026-19123.
    >> Share

  48. MOAVEN O
    Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?
    Ann Surg Oncol. 2026 Jan 20. doi: 10.1245/s10434-026-19095.
    >> Share

  49. ZHOU Y, Zuo Z, Zhao J, Liu L, et al
    ASO Author Reflections: Time-to-Event Machine Learning for Prognostication of Locally Advanced Colorectal Cancer: Insights into Current Progress and Future Directions.
    Ann Surg Oncol. 2026 Jan 18. doi: 10.1245/s10434-025-18949.
    >> Share

  50. ZHENG X, Pinheiro LC, Tehranifar P, Phillips E, et al
    ASO Visual Abstract: Short- and Long-term Patient Outcomes in Hospitals Primarily Serving Colorectal Cancer Patients from High-Poverty Areas-An Observational Cohort Study.
    Ann Surg Oncol. 2026 Jan 16. doi: 10.1245/s10434-025-19060.
    >> Share

  51. AL MAHRIZI AD, Mossolem F
    ASO Author Reflections: Clinical Promise of Platinum Prophylactic Intraperitoneal Chemotherapy in Colorectal Cancer.
    Ann Surg Oncol. 2026 Jan 6. doi: 10.1245/s10434-025-19002.
    >> Share

  52. BOND MJG, Bolhuis K, Linders TC, Mijnals C, et al
    ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2026 Jan 4. doi: 10.1245/s10434-025-18866.
    >> Share

  53. SASSUN R, Sileo A, Ng JC, Mari G, et al
    Low Versus High Ligation of Inferior Mesenteric Artery in Rectal and Sigmoid Cancers: A Systematic Review, Meta-analysis, and Trial Sequential Analysis of Randomized Controlled Trials.
    Ann Surg Oncol. 2026;33:210-219.
    >> Share

  54. YOHANATHAN L, Baker T
    Transplant Oncology-A New Frontier in Liver Cancer Care.
    Ann Surg Oncol. 2026;33:561-567.
    >> Share

  55. DE ROSE AM, Panettieri E, Lendoire M, Nakao Y, et al
    Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:599-608.
    >> Share

  56. SEKHON INDERJIT SINGH HK, Lord A, Pawa N, Brown G, et al
    The Prognostic Impact of Imaging Detected Tumor Deposits in Rectal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2026;33:199-209.
    >> Share

  57. CYR-CRONIER J, Lebel-Guay F, Sideris L, Gervais MK, et al
    Radiologic and Pathologic Response as Predictors of Survival in Patients with Colorectal Peritoneal Metastases Undergoing Neoadjuvant Chemotherapy Followed by CRS-HIPEC: A Retrospective Study.
    Ann Surg Oncol. 2026;33:426-434.
    >> Share

    December 2025
  58. VALDES N, Diaz L, Torrico P, Crespo I, et al
    ASO Visual Abstract: Targeted Preoperative Nutritional Support Within an Enhanced Recovery After Surgery Program for Malnourished Colorectal Cancer Patients: Postoperative Outcomes Comparable to Well-Nourished Patients in a Prospective Single-Center C
    Ann Surg Oncol. 2025 Dec 29. doi: 10.1245/s10434-025-18932.
    >> Share

  59. BAO W, Wang T, Wang Y, Chen L, et al
    Causal Inference and Prognostic Modeling in Colorectal Cancer through Integration of Computational Pathology and Mendelian Randomization.
    Ann Surg Oncol. 2025 Dec 26. doi: 10.1245/s10434-025-18901.
    >> Share

  60. BAO W
    ASO Author Reflections: Bridging the Gut-Immune Axis and Histology: A Novel Computational Approach to Colorectal Cancer.
    Ann Surg Oncol. 2025 Dec 26. doi: 10.1245/s10434-025-18972.
    >> Share

  61. HANEVELT J, Rademaker E, Zamaray B, Brohet RM, et al
    Depth of Tumor Invasion (T-Stage) is Not Associated with Survival or Recurrence Rates in Patients Undergoing Surgery for pT1 and pT2 Colon Cancer.
    Ann Surg Oncol. 2025 Dec 24. doi: 10.1245/s10434-025-18735.
    >> Share

  62. HANEVELT J, Rademaker E, Zamaray B, Brohet RM, et al
    ASO Visual Abstract: Depth of Tumor Invasion (T-stage) is not Associated with Survival or Recurrence Rates in Patients Undergoing Surgery for pT1 and pT2 Colon Cancer.
    Ann Surg Oncol. 2025 Dec 23. doi: 10.1245/s10434-025-18896.
    >> Share

  63. WU Y, Xie Y, Lin J, Cui J, et al
    ASO Visual Abstract: CD103-Positive Tumor-Infiltrating Lymphocytes Predict a Favorable Prognosis in Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2025 Dec 22. doi: 10.1245/s10434-025-18201.
    >> Share

  64. AL MAHRIZI AD, Mossolem F, Major E, Elshafei O, et al
    Prophylactic Intraperitoneal Chemotherapy with Platinum Agents Following Curative Resection for Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18903.
    >> Share

  65. VALDES N
    ASO Author Reflections: Can Targeted Nutrition Level the Playing Field? Reflections on Preoperative Support for Malnourished Colorectal Cancer Patients in ERAS.
    Ann Surg Oncol. 2025 Dec 11. doi: 10.1245/s10434-025-18832.
    >> Share

  66. ZHENG X, Pinheiro LC, Tehranifar P, Phillips E, et al
    Short-and Long-term Patient Outcomes in Hospitals Primarily Serving Patients with Colorectal Cancer from High-Poverty Areas-An Observational Cohort Study.
    Ann Surg Oncol. 2025 Dec 6. doi: 10.1245/s10434-025-18816.
    >> Share

  67. BOYER ME, Fleming FJ
    Rethinking Surgical Extent-Long-term Outcomes after Resection of T1 and T2 Colon Cancer.
    Ann Surg Oncol. 2025 Dec 3. doi: 10.1245/s10434-025-18831.
    >> Share

  68. ZHOU Y, Zuo Z, Zhao J, Tan Y, et al
    Development and Validation of Time-to-Event Machine Learning Models for Predicting Disease-Free Survival in Patients with Locally Advanced Colorectal Cancer: A Multicenter Cohort Study.
    Ann Surg Oncol. 2025 Dec 2. doi: 10.1245/s10434-025-18815.
    >> Share

  69. MARZI S, Vidiri A, Ianiro A, Parrino C, et al
    CT-Based Radiomics Models with External Validation for Prediction of Recurrence and Disease-Specific Mortality After Radical Surgery of Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:9584-9596.
    >> Share

  70. SAITO Y, Morine Y, Yamada S, Teraoku H, et al
    Innovative Robotic Liver Resection with Extended Reality for Both Navigation and Medical Education by Three Separate Surgeons.
    Ann Surg Oncol. 2025;32:9630.
    >> Share

  71. BOUBADDI M, Pluchon A, Marichez A, Amintas S, et al
    Local Regrowth After a Watch-and-Wait Strategy for Middle and Low Rectal Cancer: Is Organ Preservation Still Feasible?
    Ann Surg Oncol. 2025;32:9502-9509.
    >> Share

  72. RAQUEL SG, Cate DWGT, Lopez-Baamonde M, Bojesen RD, et al
    Adherence, Compliance Rates, and Response to Training Among Patients Awaiting Colorectal Cancer Surgery: A Secondary Analysis From the PREHAB Multicentre Trial.
    Ann Surg Oncol. 2025 Dec 1. doi: 10.1245/s10434-025-18668.
    >> Share

    November 2025
  73. HOUBIERS A, Barbe R, Durand-Labrunie J, Bani MA, et al
    ASO Author Reflections: Future Role of Radiochemotherapy in the Multimodal Management of Retroperitoneal Lymph Node Metastases From Colorectal Cancer.
    Ann Surg Oncol. 2025 Nov 17. doi: 10.1245/s10434-025-18277.
    >> Share

  74. BOND MJG, Bolhuis K, Linders TC, Mijnals C, et al
    Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Nov 14. doi: 10.1245/s10434-025-18696.
    >> Share

  75. SCHAFER L, Holzner PA, Menzel M, Stoger GJ, et al
    ASO Visual Abstract: Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes.
    Ann Surg Oncol. 2025 Nov 9. doi: 10.1245/s10434-025-18583.
    >> Share

  76. WU Y, Xie Y, Lin J, Cui J, et al
    CD103-Positive Tumor-Infiltrating Lymphocytes Predict a Favorable Prognosis in Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2025 Nov 6. doi: 10.1245/s10434-025-17977.
    >> Share

    October 2025
  77. SHIMIZU H, Kurashima K, Fukami T, Miyoshi T, et al
    ASO Author Reflections: Glutaredoxin 2 has Potential as a Therapeutic Target for Colon Cancer.
    Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18632.
    >> Share

  78. LADAGE VP, Ramkumar N, Wang Q, O'Malley AJ, et al
    ASO Visual Abstract: Rurality and Use of Metastasis-Directed Therapies in Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Oct 18. doi: 10.1245/s10434-025-18586.
    >> Share

  79. BRAUNER KB, Mashkoor M, Gogenur M, Lin V, et al
    ASO Visual Abstract: The Association between Conducting a Multidisciplinary Team Conference and Short- and Long-Term Outcomes After Colorectal Cancer Surgery-A National Register Study.
    Ann Surg Oncol. 2025 Oct 15. doi: 10.1245/s10434-025-18559.
    >> Share

  80. HOUBIERS A, Barbe R, Durand-Labrunie J, Boige V, et al
    Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis.
    Ann Surg Oncol. 2025 Oct 14. doi: 10.1245/s10434-025-18106.
    >> Share

  81. CYR-CRONIER J
    ASO Author Reflections: Radiology Meets Pathology-Identifying the Right Patients for CRS-HIPEC in Colorectal Cancer.
    Ann Surg Oncol. 2025 Oct 12. doi: 10.1245/s10434-025-18523.
    >> Share

  82. ERKAYA M, Benlice C, Karahan S, Oruc M, et al
    ASO Visual Abstract: Adjuvant Chemotherapy and Survival in MSI-High Stage II and III Colon Cancer: Impact of Histopathological Risk Stratification.
    Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18485.
    >> Share

  83. MARINCOLA SMITH P, White MG
    ASO Author Reflections: Role of Repeat Cytoreductive Surgery for Patients with Recurrent Colorectal-Cancer-Related Peritoneal Metastases.
    Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18522.
    >> Share

  84. ERKAYA M, Benlice C, Karahan S, Oruc M, et al
    Adjuvant Chemotherapy and Survival in MSI-High Stages II and III Colon Cancer: Impact of Histopathologic Risk Stratification.
    Ann Surg Oncol. 2025 Oct 7. doi: 10.1245/s10434-025-18285.
    >> Share

  85. HEIL J, Sliwinski S, D'Haese J, Fangmann J, et al
    Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry.
    Ann Surg Oncol. 2025;32:7183-7194.
    >> Share

  86. CLEMENT E, Alam A, Lange C, Lin W, et al
    The Impact of Multidisciplinary Conference on Clinicians.
    Ann Surg Oncol. 2025;32:7344-7350.
    >> Share

  87. APEL R, Sulimani O, Perl G, Abitbol C, et al
    Israel's First Port-Based Hepatic Artery Infusion Program: Early Outcomes in Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:7200-7208.
    >> Share

  88. ABOELMAATY S, Gomaa IA, Sileo A, Sassun R, et al
    The Impact of RAS/BRAF Mutation on Pathological Complete Response After Total Neoadjuvant Therapy in Rectal Cancer.
    Ann Surg Oncol. 2025;32:7326-7332.
    >> Share

  89. WANG A, Ying J, Zhang J, Zhu X, et al
    Simultaneous Vaginoplasty with Acellular Dermal Matrix and Pedicled Omental Flap and Pull-Through Colon-Anal Anastomosis for Low Rectal Cancer with Vaginal Invasion.
    Ann Surg Oncol. 2025;32:7351-7352.
    >> Share

  90. ZHUANG Z, Yang X, Zhang Y, Deng X, et al
    Discrepancies in the Reactivity of Mesorectal versus Lateral Lymph Nodes Post-Neoadjuvant Chemoradiotherapy for Rectal Cancer: Insights from Radiological and Pathological Perspectives.
    Ann Surg Oncol. 2025;32:7293-7303.
    >> Share

  91. LIU A, Reason EH, Sullivan BG, Wildman-Tobriner B, et al
    Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
    Ann Surg Oncol. 2025;32:7131-7140.
    >> Share

  92. OCHIAI K, Hida K, Yamaguchi T, Fukuda M, et al
    Risk Factors for and Oncologic Impact of Anastomotic Leakage After Sphincter-Preserving Proctectomy for Mid/Low Rectal Cancer: A Multi-institutional Cohort Study in Japan.
    Ann Surg Oncol. 2025;32:7315-7325.
    >> Share

  93. ZHAO J, Zheng P, Xu T, Feng Q, et al
    Preoperative Assessment of Lymph Node Metastasis in Rectal Cancer Using Deep Learning: Investigating the Utility of Various MRI Sequences.
    Ann Surg Oncol. 2025;32:7304-7314.
    >> Share

    September 2025
  94. SCHAFER L, Holzner PA, Menzel M, Stoger GJ, et al
    Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes.
    Ann Surg Oncol. 2025 Sep 30. doi: 10.1245/s10434-025-18407.
    >> Share

  95. BRAUNER KB, Mashkoor M, Gogenur M, Lin V, et al
    The Association Between Conducting a Multidisciplinary Team Conference and Short- and Long-Term Outcomes After Colorectal Cancer Surgery: A National Register Study.
    Ann Surg Oncol. 2025 Sep 30. doi: 10.1245/s10434-025-18353.
    >> Share

  96. LADAGE VP, Ramkumar N, Wang Q, O'Malley AJ, et al
    Rurality and Use of Metastasis-Directed Therapies for Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18412.
    >> Share

  97. MARINCOLA SMITH P, Lie JJ, Seldomridge A, Galbraith NJ, et al
    Repeat Cytoreductive Surgery for Colorectal Cancer Metastatic to the Peritoneal Cavity.
    Ann Surg Oncol. 2025 Sep 27. doi: 10.1245/s10434-025-18421.
    >> Share

  98. KONG D, Li Y, Yin S, Tan Y, et al
    ASO Visual Abstract: Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Stage II-III Colorectal Cancer Patients.
    Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18368.
    >> Share

  99. OCHIAI K, Bhutiani N
    The Evolving Multidisciplinary Management of Retroperitoneal Lymph Node Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2025 Sep 9. doi: 10.1245/s10434-025-18321.
    >> Share

  100. YANG H, Zeng Q, Zhou Y, Jiang P, et al
    Two Levels of High Ligation of the Inferior Mesenteric Artery Based on Three Anatomical Fasciae for Colorectal Cancer (with Video).
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18224.
    >> Share

  101. HOUBIERS A, Barbe R, Durand-Labrunie J, Boige V, et al
    ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18291.
    >> Share

  102. WACH MM, Dineen SP
    ASO Practice Guideline Series: Management of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2025;32:6589-6603.
    >> Share

  103. FERNANDEZ M, Todeschini L, Keenan BP, Rosenberg D, et al
    Novel Computational Analysis Identifies Cytotoxic Lymphocyte-to-Monocyte Balance in Tumors as a Predictor of Recurrence-Free Survival in Colorectal Carcinoma.
    Ann Surg Oncol. 2025;32:6980-6990.
    >> Share

  104. DA SILVA DC, Sousa F, Silva A, Sousa-Pinto B, et al
    Risk Factors for Gastric Cancer in Patients with Lynch Syndrome: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2025;32:6877-6883.
    >> Share

  105. VAN GEFFEN EGM, Konishi T, Hazen SJA, Sluckin TC, et al
    Evaluation of Short-Term Postoperative Outcomes of Lateral Lymph Node Dissection After Neoadjuvant Radiotherapy for Rectal Cancer Patients: The Early Learning Phase After Surgical Training in the Netherlands.
    Ann Surg Oncol. 2025;32:6708-6719.
    >> Share

  106. SEOW W, Murshed I, Bunjo Z, Bedrikovetski S, et al
    Compliance and Toxicity of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.
    Ann Surg Oncol. 2025;32:6728-6739.
    >> Share

  107. KONG D, Li Y, Yin S, Tan Y, et al
    Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Patients with Stage II-III Colorectal Cancer.
    Ann Surg Oncol. 2025 Sep 1. doi: 10.1245/s10434-025-18176.
    >> Share

    August 2025
  108. NAKAMICHI N, Shiozaki A, Shimizu H, Otsuji E, et al
    ASO Author Reflections: The Function and Clinical Significance of TRPV2 in Human Colon Cancer.
    Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18228.
    >> Share

  109. CHIU CC, Hsieh MC, Wang GL, Shi HY, et al
    Quality of Life and Minimal Clinically Important Difference in Colorectal Cancer Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy: A Large Prospective Cohort Study.
    Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18147.
    >> Share

  110. HANSEN IS, Lappen KR, Brudvik KW, Rosok BI, et al
    A Randomized Controlled Trial of Resection Versus Thermal Ablation of Colorectal Cancer Liver Metastases (New Comet): Study Protocol.
    Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-17984.
    >> Share

  111. NIE Y, Kumamoto Y, Yamashita K
    ASO Author Reflections: Cancer Stroma and SPARC are Involved in the Molecular Mechanisms of Poor Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18111.
    >> Share

  112. NIE Y, Fujiyama Y, Shibaki S, Okamoto R, et al
    SPARC Induces COL1A1/COL3A1 Expressions Representing Aggressive Molecular Cancer-Associated Fibroblasts Signatures and CSF1-Mediated Cancer Invasion in Colorectal Cancer.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18039.
    >> Share

  113. NAKAMICHI N, Shiozaki A, Kosuga T, Shimizu H, et al
    The Function and Clinical Significance of TRPV2 in Human Colon Cancer.
    Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18083.
    >> Share

  114. LIU D, Cai J
    Reply to: "An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer", by Mo et al.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18048.
    >> Share

  115. DE LANGAVANT BC, Kefleyesus A, Peron J, Glehen O, et al
    Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical History.
    Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-18022.
    >> Share

  116. LABADIE KP, Melstrom LG
    ASO Author Reflections: Optimizing the Dose of Floxuridine for the Adjuvant Treatment of Resected Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-17994.
    >> Share

  117. KATO S, Miyoshi N, Fujino S, Horie M, et al
    ASO Visual Abstract: Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17971.
    >> Share

  118. BADER JM, Ospina A, Liu S, Reddy B, et al
    A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis.
    Ann Surg Oncol. 2025;32:5784-5794.
    >> Share

  119. TONELLO M, Cenzi C, Pizzolato E, Martini M, et al
    National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis.
    Ann Surg Oncol. 2025;32:5795-5806.
    >> Share

  120. WANG LJ, Bao Q, Wang HW, Huang LF, et al
    Predictive Factors for Chemotherapy Response in Colorectal Liver Metastasis: A Retrospective Study Utilizing Next-Generation Sequencing.
    Ann Surg Oncol. 2025;32:6067-6079.
    >> Share

  121. LINDENLAUB F, Asenbaum U, Schwarz C, Makolli J, et al
    Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:5667-5674.
    >> Share

  122. GOHDA Y, Yano H, Suda R, Mirnezami A, et al
    Repeat Diagnostic Laparoscopy After Chemotherapy is Useful in Patient Selection for Conversion to Cytoreductive Surgery for Initially Unresectable Colorectal and Appendiceal Peritoneal Metastases: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025;32:5774-5783.
    >> Share

    July 2025
  123. KATO S, Miyoshi N, Fujino S, Horie M, et al
    Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17765.
    >> Share

  124. LABADIE KP, Fan D, Dominguez D, Wong P, et al
    ASO Visual Abstract: Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17928.
    >> Share

  125. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    Reply to: "Concerns Regarding Study Selection and Methodological Rigor in Meta-Analysis on Neoadjuvant Chemotherapy for Colon Cancer".
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17997.
    >> Share

  126. LABADIE KP, Fan D, Dominguez DA, Wong P, et al
    Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17783.
    >> Share

  127. NORONHA MM, Leite LF, Peixoto RD
    Concerns Regarding Study Selection and Methodological Rigor in Meta-Analysis on Neoadjuvant Chemotherapy for Colon Cancer.
    Ann Surg Oncol. 2025 Jul 20. doi: 10.1245/s10434-025-17903.
    >> Share

  128. MO Q, Zheng J, Liu C
    Letter to "An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer".
    Ann Surg Oncol. 2025 Jul 16. doi: 10.1245/s10434-025-17771.
    >> Share

  129. ZUO D, Wang L, Jin K, Zhang Y, et al
    Genomic and Clinical Predictors of Conversion in Initially Unresectable Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17809.
    >> Share

  130. KHALIL M, Pawlik TM
    ASO Author Reflections: The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
    Ann Surg Oncol. 2025 Jul 3. doi: 10.1245/s10434-025-17754.
    >> Share

  131. RAICHURKAR P, Brown KGM, White K, Koh CE, et al
    Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: A Qualitative Exploration of the Lived Experiences of Patients and Carers.
    Ann Surg Oncol. 2025;32:5042-5050.
    >> Share

  132. PEREZ RO, Vailati BB, Sao Juliao GP, Mazzucato F, et al
    The Landmark Series: Organ Preservation in Rectal Cancer-The Watch and Wait Strategy.
    Ann Surg Oncol. 2025;32:4945-4956.
    >> Share

  133. BUNJO Z, Sammour T
    The Landmark Series: Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2025;32:4935-4944.
    >> Share

  134. ZIVANOV CN, Kau NS, Nalluri-Butz H, Oduyale OK, et al
    Nonoperative Management of Rectal Cancer: Is "Near-Complete" Response Safe to Surveil?
    Ann Surg Oncol. 2025;32:4922-4930.
    >> Share

    June 2025
  135. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363.
    >> Share

  136. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    ASO Visual Abstract: Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-analysis, and Sequential Analysis.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17722.
    >> Share

  137. KHALIL M, Woldesenbet S, Rashid Z, Altaf A, et al
    The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
    Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17711.
    >> Share

  138. TODESCHINI L, Hernandez S, Maker AV
    ASO Author Reflections: Precision Immunoprofiling of the Tumor Microenvironment Predicts Recurrence in Advanced Colorectal Cancer.
    Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17728.
    >> Share

  139. SASSUN R, Sileo A, Ng JC
    ASO Author Reflections: Toward a New Standard: The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17677.
    >> Share

  140. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-Analysis, and Sequential Analysis.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17640.
    >> Share

  141. SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
    Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
    Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17404.
    >> Share

  142. TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
    ASO Visual Abstract: Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17620.
    >> Share

  143. SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
    ASO Visual Abstract: Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
    Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17582.
    >> Share

  144. TAQI K, Icchhpuniani S, Stockley C, Elmi Assadzadeh G, et al
    ASO Visual Abstract: Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS & HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis.
    Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17569.
    >> Share

  145. VAN KESTEREN LJ, Moolenaar LR, Nieuwenhuijzen JA, de Bruijn V, et al
    Double-Barrel Urocolostomy After Pelvic Exenteration: Short-Term Morbidity and Patient-Reported Quality of Life.
    Ann Surg Oncol. 2025;32:4534-4541.
    >> Share

  146. JIRATHANIRUANGKIT K, Sainont G, Malakorn S
    Stepwise Approach for Robotic Total Pelvic Exenteration with En Bloc Presacral Fascia in T4b Rectal Cancer.
    Ann Surg Oncol. 2025;32:4250-4251.
    >> Share

  147. KIM SJ, Shen C, Moheb ME, Cummins KC, et al
    Sociodemographic Disparities in Rectal Cancer Outcomes within Academic Cancer Centers.
    Ann Surg Oncol. 2025;32:3889-3899.
    >> Share

  148. LAPERGOLA A, Melani AG, D'Urso A, Reitano E, et al
    Laparoscopic Oncologic Splenic Flexure Resection: A Complete Mesocolic Excision with Concomitant Inferior Mesenteric Artery and Vein Preservation.
    Ann Surg Oncol. 2025;32:4252-4255.
    >> Share

  149. MERKOW RP, Cavnar MJ, Gleisner AL, Mayo SC, et al
    Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective.
    Ann Surg Oncol. 2025;32:4408-4416.
    >> Share

    May 2025
  150. LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
    ASO Visual Abstract: Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon-Cancer-Directed Surgery in the United States.
    Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17469.
    >> Share

  151. TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
    Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 May 22. doi: 10.1245/s10434-025-17486.
    >> Share

  152. TAQI K, Icchhpuniani S, Stockley C, Assadzadeh GE, et al
    Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis.
    Ann Surg Oncol. 2025 May 15. doi: 10.1245/s10434-025-17321.
    >> Share

  153. BHUTIANI N, Ochiai K, Peacock O, You YN, et al
    Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer.
    Ann Surg Oncol. 2025;32:3098-3105.
    >> Share

  154. NG JC, Sileo A, Sassun R, Aboelmaaty S, et al
    Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2025;32:3089-3097.
    >> Share

  155. LI ZF, Zhang JN, Tian S, Sun C, et al
    Dual-Time-Point Radiomics for Prognosis Prediction in Colorectal Liver Metastasis Treated with Neoadjuvant Therapy Before Radical Resection: A Two-Center Study.
    Ann Surg Oncol. 2025;32:3516-3525.
    >> Share

  156. KAWASHIMA J, Akabane M, Endo Y, Woldesenbet S, et al
    A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size.
    Ann Surg Oncol. 2025;32:3505-3515.
    >> Share

  157. GREENSPUN BC, Metzger DA, Foshag A, Marshall TE, et al
    Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors: Is Surveillance a Feasible Option?
    Ann Surg Oncol. 2025;32:3112-3118.
    >> Share

  158. SCHLEIMER LE, Liu A, Kalvin HL, Barekzai AB, et al
    Robotic Versus Open Placement of Hepatic Artery Infusion Pumps.
    Ann Surg Oncol. 2025;32:3488-3498.
    >> Share

  159. ENBLAD M, Cashin P, Ghanipour L, Graf W, et al
    Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering Analysis.
    Ann Surg Oncol. 2025;32:3638-3647.
    >> Share

  160. ZHAN Z, Chen B, Lin W, Chen X, et al
    Rising Burden of Colon and Rectum Cancer in China: An Analysis of Trends, Gender Disparities, and Projections to 2030.
    Ann Surg Oncol. 2025;32:3361-3371.
    >> Share

  161. EIKENBOOM EL, Nasar N, Seier K, Gonen M, et al
    Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.
    Ann Surg Oncol. 2025;32:3568-3577.
    >> Share

    April 2025
  162. TAQI K, Mack L, Bouchard-Fortier A
    ASO Authors Reflections: Beyond the Boundaries of Colorectal Cancer Peritoneal and Liver Metastases: Insights from a Systematic Review.
    Ann Surg Oncol. 2025 Apr 29. doi: 10.1245/s10434-025-17395.
    >> Share

  163. LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
    Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon Cancer-Directed Surgery in the United States.
    Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17266.
    >> Share

  164. MANGIERI CW, Votanopoulos KI, Shen P, Levine EA, et al
    Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?
    Ann Surg Oncol. 2025;32:2893-2902.
    >> Share

  165. WALE A, Harris H, Brown G
    Diagnostic Certainty in Characterizing Liver Lesions in Rectal Cancer: Abbreviated Liver MRI versus CT.
    Ann Surg Oncol. 2025;32:2435-2445.
    >> Share

  166. MAKI H, Ayabe RI, Haddad A, Nishioka Y, et al
    Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:2425-2434.
    >> Share

  167. SILEO A, Sassun R, Ng JC, Aboelmaaty S, et al
    Age Matters: Early-Onset Rectal Cancer Exhibits Higher Rates of Pathological Complete Response: A Retrospective Analysis of the Influence of Young Age on Treatment Success in Stage II-III Rectal Cancer.
    Ann Surg Oncol. 2025;32:2302-2307.
    >> Share

  168. WANG A, Zhang P, Zang J, Zhang X, et al
    Total Pelvic Exenteration with Presacral Fascia and Pelvic Musculature Excision for Pelvic Recurrence of Rectal Cancer.
    Ann Surg Oncol. 2025;32:2308-2309.
    >> Share

  169. COUBEAU L, Foguenne M, Marique L, Bonaccorsi Riani E, et al
    RAPID-Type Auxiliary Liver Transplantation for Unresectable Colorectal Liver Metastases: A First-Stage Surgical Video.
    Ann Surg Oncol. 2025;32:2300-2301.
    >> Share

  170. FALLON EA, Awiwi MO, Bhutiani N, Helmink B, et al
    Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis.
    Ann Surg Oncol. 2025;32:2923-2931.
    >> Share

  171. GAN Y, Hu Q, Shen Q, Lin P, et al
    Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.
    Ann Surg Oncol. 2025;32:3019-3030.
    >> Share

  172. TROESTER A, Weaver L, Mott SL, Welton L, et al
    Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United States.
    Ann Surg Oncol. 2025;32:2271-2281.
    >> Share

  173. MOYA-MENDEZ ME, Schaps D, Penvose KN, Chang D, et al
    Weekly Patient-Reported Venous Thromboembolism Prophylaxis Adherence After Colorectal Cancer Surgery.
    Ann Surg Oncol. 2025 Apr 1. doi: 10.1245/s10434-025-17267.
    >> Share

    March 2025
  174. METZGER DA, Greenspun BC, Brouwer J, Li Y, et al
    ASO Visual Abstract: Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
    Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17163.
    >> Share

  175. ENGLUM BR, Sahoo S, Mayorga-Carlin M, Siddiqui T, et al
    Disparities in Colorectal Cancer Screening and Diagnoses in the COVID Era: A Study of the VA Health System.
    Ann Surg Oncol. 2025 Mar 20. doi: 10.1245/s10434-025-17153.
    >> Share

  176. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
    ASO Visual Abstract: Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.
    Ann Surg Oncol. 2025 Mar 3. doi: 10.1245/s10434-025-17071.
    >> Share

  177. KENARY PY, Ross S, Sucandy I
    Robotic Subtotal Caudate Lobe Hepatic Resection for Paracaval Colorectal Metastasis: Technique of Inferior Vena Cava Dissection and Handling.
    Ann Surg Oncol. 2025;32:1769-1770.
    >> Share

  178. HADDAD A, Khavandi MM, Lendoire M, Acidi B, et al
    Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration.
    Ann Surg Oncol. 2025;32:1752-1761.
    >> Share

  179. KOBAYASHI K, Inoue Y, Oba A, Ono Y, et al
    Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary Treatment.
    Ann Surg Oncol. 2025;32:1729-1741.
    >> Share

    February 2025
  180. METZGER D, Greenspun B, Siolas D, Jafari M, et al
    ASO Author Reflections: Risk Stratification Using Genomic Data for Early-Stage Colon Cancer.
    Ann Surg Oncol. 2025 Feb 26. doi: 10.1245/s10434-025-17089.
    >> Share

  181. SAMMOUR T
    Invited Editorial: "Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study," by Nozawa et al.
    Ann Surg Oncol. 2025 Feb 26. doi: 10.1245/s10434-025-17044.
    >> Share

  182. DHIMAL T, Fleming FJ
    Neoadjuvant Immunotherapy in Operable Colon Cancer: Opportunities and Challenges.
    Ann Surg Oncol. 2025 Feb 23. doi: 10.1245/s10434-025-17043.
    >> Share

  183. METZGER DA, Greenspun BC, Brouwer J, Li Y, et al
    Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-17014.
    >> Share

  184. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
    ASO Author Reflections: Pushing the Boundaries of Local Excision: How Does the Risk of Lymph Node Metastases Compare to Those Associated with Major Surgery in T2 Colon Cancer Patients?
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16997.
    >> Share

  185. MI SY, Liao YJ, Kang D, Tang X, et al
    Decreasing Use of CT in Favor of Colonoscopy: A Retrospective Analysis of Post-Operative Imaging in Nonmetastatic dMMR/MSI-H Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16989.
    >> Share

  186. SCHLEIMER LE, Hakki L, Seier K, Seo SK, et al
    Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.
    Ann Surg Oncol. 2025;32:1043-1053.
    >> Share

  187. LIU A, Lowe M, Niedzwiecki D, Rhodin KE, et al
    Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program.
    Ann Surg Oncol. 2025;32:1033-1042.
    >> Share

  188. LIMA DE ARAUJO CA, de Freitas Busnardo F, Thome Grillo VA, Chirnev Felicio CH, et al
    Effect of Early Postoperative Mobilization on Functional Recovery, Hospital Length of Stay, and Postoperative Complications After Immediate Internal Pudendal Artery Perforator Flap Reconstruction for Irradiated Abdominoperineal Resection Defects: A Pr
    Ann Surg Oncol. 2025;32:993-1004.
    >> Share

  189. LIU LL, Lin YK, Xiang ZL
    The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.
    Ann Surg Oncol. 2025;32:1083-1092.
    >> Share

  190. WINICKI NM, Radomski SN, Florissi IS, Wethington S, et al
    Management of the Uninvolved Uterus and Adnexa During Routine Pelvic Peritonectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Varies by Histology and Menopausal Status: An International Survey of Peritoneal Surface Malignan
    Ann Surg Oncol. 2025;32:671-678.
    >> Share

    January 2025
  191. KANANI A, Veen T, Lea D, Zaharia C, et al
    ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair-Modelling Oncological Outcomes and Numbers Needed to Treat.
    Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16899.
    >> Share

  192. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
    Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.
    Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16921.
    >> Share

  193. KANANI A, Veen T, Lea D, Zaharia C, et al
    Correction: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-025-16888.
    >> Share

  194. TIDADINI F, Arvieux C, Glehen O, Sourrouille I, et al
    Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers.
    Ann Surg Oncol. 2025;32:209-220.
    >> Share

  195. MATHEW J, Kazi M, Desouza A, Saklani A, et al
    Postoperative Morbidity and Factors Predicting the Development of Lymphoceles Following Lateral Pelvic Node Dissection for Rectal Cancer: A Cohort Study.
    Ann Surg Oncol. 2025;32:165-175.
    >> Share

  196. FEFERMAN Y, Verheij FS, Williams H, Omer DM, et al
    Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection.
    Ann Surg Oncol. 2025;32:128-136.
    >> Share

  197. SASAKI K, Wang J, Kamphues C, Buettner S, et al
    Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study.
    Ann Surg Oncol. 2025;32:408-417.
    >> Share

  198. MURSHED I, Bunjo Z, Seow W, Murshed I, et al
    Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.
    Ann Surg Oncol. 2025;32:137-157.
    >> Share

    December 2024
  199. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
    ASO Visual Abstract: Disparities in Palliative Treatment Utilization in Patients with Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2024 Dec 31. doi: 10.1245/s10434-024-16749.
    >> Share

  200. AREZO K, Torhild V, Dordi L, Claudia Z, et al
    Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat.
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16755.
    >> Share

  201. EL MOHEB M, Shen C, Kim S, Putman K, et al
    ASO Visual Abstract: Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16695.
    >> Share

  202. QIN Y, Miyake T, Muramoto K, Maekawa T, et al
    ASO Visual Abstract: Fibroblast Activation Protein-alpha Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregula
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16750.
    >> Share

  203. ZHENG J, Wang T, Wang H, Yan B, et al
    ASO Visual Abstract: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2024 Dec 26. doi: 10.1245/s10434-024-16680.
    >> Share

  204. MOHEB ME, Tsung A
    ASO Author Reflections: Decoding Racial Differences in Colon Cancer Transcriptomes.
    Ann Surg Oncol. 2024 Dec 7. doi: 10.1245/s10434-024-16682.
    >> Share

  205. PATEL DD, Dickson PV
    Invited Editorial About: "Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer," by C. Komine et al.
    Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16609.
    >> Share

  206. QIN Y, Miyake T, Muramoto K, Maekawa T, et al
    Fibroblast Activation Protein-alpha Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survi
    Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16593.
    >> Share

  207. KARAGKOUNIS G, Horvat N, Danilova S, Chhabra S, et al
    Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After Chemotherapy.
    Ann Surg Oncol. 2024;31:9196-9204.
    >> Share

  208. RISBEY CWG, Brown KGM, Solomon M, McBride K, et al
    Cost Analysis of Pelvic Exenteration Surgery for Advanced Pelvic Malignancy.
    Ann Surg Oncol. 2024;31:9079-9087.
    >> Share

  209. PALMIERI L, Santullo F, Lodoli C, Certelli C, et al
    Robotic Recto-Sigmoid Resection with Total Intracorporeal Colorectal Anastomosis (TICA) in Recurrent Ovarian Cancer.
    Ann Surg Oncol. 2024;31:8952-8953.
    >> Share

  210. ALLIEVI N, Sidhom M, Samuel MV, Tzivanakis A, et al
    Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2024;31:8585-8595.
    >> Share

    November 2024
  211. ZHENG J, Wang T, Wang H, Yan B, et al
    Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16519.
    >> Share

  212. LIU D, Chen Z, Deng W, Lan J, et al
    ASO Visual Abstract: An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16599.
    >> Share

  213. LIU D, Chen Z, Deng W, Lan J, et al
    An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 26. doi: 10.1245/s10434-024-16469.
    >> Share

  214. EL MOHEB M, Shen C, Kim S, Putman K, et al
    Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
    Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16550.
    >> Share

  215. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
    Disparities in Palliative Treatment Utilization in Metastatic Colorectal Cancer Patients.
    Ann Surg Oncol. 2024 Nov 22. doi: 10.1245/s10434-024-16577.
    >> Share

  216. KHORFAN R, Sedighim S, Caba-Molina D, Tran TB, et al
    National Trends and Outcomes in Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases Before and After PRODIGE 7.
    Ann Surg Oncol. 2024 Nov 21. doi: 10.1245/s10434-024-16539.
    >> Share

  217. MEN V, Jin JZ
    ASO Author Reflections: Lymph Node Yield and Long-Term Survival in Colon Cancer-Insights from a 20-Year National Study.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16565.
    >> Share

  218. LIU D, Yang K, Cai J
    ASO Author Reflections: Organoid Model to Aid the Decision of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16555.
    >> Share

  219. ZHENG J, Wang T, Wang S, Ji H, et al
    ASO Author Reflections: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16576.
    >> Share

  220. MEN V, Bahl P, Jin JZ, Singh PP, et al
    ASO Visual Abstract: Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
    Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16513.
    >> Share

  221. NOZAWA H, Ito S, Sasaki K, Murono K, et al
    Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study.
    Ann Surg Oncol. 2024 Nov 18. doi: 10.1245/s10434-024-16537.
    >> Share

  222. HADDAD A, Lendoire M, Uppal A, Maki H, et al
    CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2024 Nov 8. doi: 10.1245/s10434-024-16370.
    >> Share

  223. ALTAF A, Woldesenbet S, Munir MM, Khan MMM, et al
    ASO Visual Abstract: Clinical Outcomes, Costs, and Value of Undergoing Surgery Among Older Patients with Colon Cancer at U.S. News & World Report Ranked Versus Unranked Hospitals.
    Ann Surg Oncol. 2024 Nov 6. doi: 10.1245/s10434-024-16406.
    >> Share

  224. MEN V, Bahl P, Jin JZ, Singh PP, et al
    Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
    Ann Surg Oncol. 2024 Nov 4. doi: 10.1245/s10434-024-16428.
    >> Share

  225. ZHANG H, Zhuo C, Lin R, Ke F, et al
    ASO Author Reflections: Why are the Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases so Important?
    Ann Surg Oncol. 2024 Nov 4. doi: 10.1245/s10434-024-16334.
    >> Share

  226. WAHEED MT, Ruel N, Whelan RL, Fakih M, et al
    Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial.
    Ann Surg Oncol. 2024;31:7998-8007.
    >> Share

  227. KAWADA K, Inamura Y, Morikawa A, Matsuoka H, et al
    Perineal-First Approach in Robotic Abdominoperineal Resection.
    Ann Surg Oncol. 2024;31:7820-7821.
    >> Share

  228. WANG A, Wang A, Xu X, Chen M, et al
    ASO Author Reflections: Simultaneous Robotic Surgery for Rectal Gastrointestinal Stromal Tumor and Prostatic Cancer.
    Ann Surg Oncol. 2024;31:7852-7853.
    >> Share

  229. HILTY CHU BK, Loria A, Dhimal T, Cupertino P, et al
    ASO Author Reflections: Improving Shared-Decision Making in Rectal Cancer.
    Ann Surg Oncol. 2024;31:7856-7857.
    >> Share

  230. HILTY CHU BK, Loria A, Dhimal T, Li Y, et al
    The Rise of Patients Declining Rectal Cancer Surgery in the Era of Total Neoadjuvant Therapy.
    Ann Surg Oncol. 2024;31:7798-7806.
    >> Share

  231. BROWN KGM, Solomon MJ
    Understanding Quality of Life After Pelvic Exenteration for Patients with Rectal Cancer.
    Ann Surg Oncol. 2024;31:7668-7670.
    >> Share

  232. WANG A, Wang A, Xu X, Chen M, et al
    Simultaneous Robotic Sphincter-Preserving Rectal Resection and Prostatectomy for Rectal Gastrointestinal Stromal Tumor and Prostatic Cancer.
    Ann Surg Oncol. 2024;31:7796-7797.
    >> Share

    October 2024
  233. KIM SJ, Park MY, Yang SY, Han YD, et al
    ASO Visual Abstract: Minimally Invasive Surgery: Is It a Risk Factor for Postoperative Peritoneal Metastasis in pT4 Colon Cancer?
    Ann Surg Oncol. 2024 Oct 10. doi: 10.1245/s10434-024-16280.
    >> Share

  234. ZHANG H, Zhuo C, Lin R, Ke F, et al
    Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases Through Analysis of Single-Cell Sequencing Data and TCGA Data.
    Ann Surg Oncol. 2024 Oct 9. doi: 10.1245/s10434-024-16194.
    >> Share

  235. STEPHENS KR, Donica WRF, Egger ME, Philips P, et al
    Observed Changes in the Distribution of Colon Cancer Metastasis: A National Cancer Database Review and Institutional Experience.
    Ann Surg Oncol. 2024 Oct 8. doi: 10.1245/s10434-024-16330.
    >> Share

  236. DOSSA F, Weiser MR
    Omission of Radiotherapy for Locally Advanced Rectal Cancer: A Step Toward Patient-Centric Treatment Decision-Making.
    Ann Surg Oncol. 2024;31:6337-6341.
    >> Share

  237. WEAVER L, Goffredo P
    ASO Author Reflections: Malignant Colon Polyps-Is Tumor Laterality the New Black?
    Ann Surg Oncol. 2024;31:6472-6473.
    >> Share

  238. WEAVER L, Boatman S, Kohn J, Mott SL, et al
    The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.
    Ann Surg Oncol. 2024;31:6452-6460.
    >> Share

  239. JEONG MH, Kang SJ, Park SY, Kwak SG, et al
    Comparison of EPIC Versus HIPEC in the Treatment of Colorectal Peritoneal Metastases and Appendix Tumors Using Inverse Probability of Treatment Weighting.
    Ann Surg Oncol. 2024;31:7111-7121.
    >> Share

  240. SCHWANTES IR, Patel RK, Kardosh A, Paxton J, et al
    A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
    Ann Surg Oncol. 2024;31:6537-6545.
    >> Share

  241. GLYNNE-JONES R
    Editorial: "Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer," by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World.
    Ann Surg Oncol. 2024;31:6344-6347.
    >> Share

  242. GOFFREDO P, Suraju MO, Mott SL, Troester AM, et al
    Pathologic Complete Response, Total Neoadjuvant Therapy and the Survival Paradox in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2024;31:6432-6442.
    >> Share

  243. TROESTER A, Hassan I, Goffredo P
    ASO Author Reflections: Not All pCRs are Created Equal in Rectal Cancer.
    Ann Surg Oncol. 2024;31:6470-6471.
    >> Share

  244. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
    Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
    Ann Surg Oncol. 2024;31:6443-6451.
    >> Share

    September 2024
  245. KOMINE C, Sohda M, Yokobori T, Shioi I, et al
    Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
    Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16195.
    >> Share

  246. KOMINE C, Sohda M, Yokobori T, Shioi I, et al
    ASO Visual Abstract: Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
    Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16285.
    >> Share

  247. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
    ASO Visual Abstract: Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer-A Matched Pair Analysis.
    Ann Surg Oncol. 2024 Sep 26. doi: 10.1245/s10434-024-16271.
    >> Share

  248. ALTAF A, Pawlik TM
    ASO Author Reflections: Clinical Outcomes, Costs, and Value of Undergoing Surgery among Older Patients with Colon Cancer at U.S. News & World Report Ranked versus Unranked Hospitals.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16274.
    >> Share

  249. KIM SJ, Park MY, Yang SY, Han YD, et al
    Minimally Invasive Surgery: Is It a Risk Factor for Postoperative Peritoneal Metastasis in pT4 Colon Cancer?
    Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16177.
    >> Share

  250. ALTAF A, Woldesenbet S, Munir MM, Khan MMM, et al
    Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with Colon Cancer at US News and World Report Ranked Versus Unranked Hospitals.
    Ann Surg Oncol. 2024 Sep 14. doi: 10.1245/s10434-024-16217.
    >> Share

  251. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
    Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis.
    Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16158.
    >> Share

  252. YU AT, Hanna DN, Li TM, Sarfaty E, et al
    Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor Outcomes.
    Ann Surg Oncol. 2024;31:6252-6261.
    >> Share

  253. LEITAO MM JR, Weiser MR, Mueller JJ
    Uterine Anastomosis with Low Anterior Resection.
    Ann Surg Oncol. 2024;31:6048.
    >> Share

  254. GOFFREDO P, Suraju MO, Mott SL, Troester AM, et al
    ASO Visual Abstract: Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2024;31:5971-5972.
    >> Share

  255. DOROUDIAN S, Osterman E, Glimelius B
    Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort.
    Ann Surg Oncol. 2024;31:5570-5584.
    >> Share

  256. SADAMORI H, Monden K, Hioki M, Iwasaki H, et al
    Liver Resection Under Total Hepatic Vascular Exclusion with In Situ Hypothermic Isolated Hepatic Perfusion for Advanced Liver Tumors.
    Ann Surg Oncol. 2024;31:5638-5639.
    >> Share

  257. NOIRET B, Piessen G, Eveno C
    ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways.
    Ann Surg Oncol. 2024;31:6274-6275.
    >> Share

  258. NOIRET B, Lenne X, Bruandet A, Piessen G, et al
    Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures.
    Ann Surg Oncol. 2024;31:6220-6227.
    >> Share

    August 2024
  259. CO LMB, Dychiao RGK, Capistrano MPR, Tayag MT, et al
    Identifying Gaps in Early-Onset Colorectal Cancer Prevention, Screening, and Treatment in the Philippines.
    Ann Surg Oncol. 2024 Aug 22. doi: 10.1245/s10434-024-16038.
    >> Share

  260. EMILE SH, Horesh N, Garoufalia Z, Dourado J, et al
    ASO Visual Abstract: Accuracy of Clinical Staging of Localized Colon Cancer-A National Cancer Database Cohort Analysis.
    Ann Surg Oncol. 2024 Aug 21. doi: 10.1245/s10434-024-16101.
    >> Share

  261. REITZ ACW, Massarweh NN
    Preoperative Staging of Colon Cancer-Picking the Lesser of Two Evils.
    Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-16052.
    >> Share

  262. CHEN M, Deng S, Cao Y, Wang J, et al
    ASO Visual Abstract: Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
    Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15989.
    >> Share

  263. STEFFENS D, Nott F, Koh C, Jiang W, et al
    ASO Visual Abstract: Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
    Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-15978.
    >> Share

  264. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
    ASO Visual Abstract: Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
    Ann Surg Oncol. 2024;31:5002-5003.
    >> Share

  265. NABATA KJ, Rai S, Zhao D, MacNeill AJ, et al
    ASO Visual Abstract: Negative Pressure Wound Therapy to Reduce Surgical Site Infections After CRS/HIPEC.
    Ann Surg Oncol. 2024;31:5219.
    >> Share

  266. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
    ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.
    Ann Surg Oncol. 2024;31:5400-5401.
    >> Share

  267. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
    ASO Visual Abstract: Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients Who Undergo Resection for Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:5217-5218.
    >> Share

    July 2024
  268. EMILE SH, Wexner SD
    ASO Author Reflections: Clinical Staging of Localized Colon Cancer: Room for Improvement.
    Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15956.
    >> Share

  269. EMILE SH, Horesh N, Garoufalia Z, Dourado J, et al
    Accuracy of Clinical Staging of Localized Colon Cancer: A National Cancer Database Cohort Analysis.
    Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15875.
    >> Share

  270. CHEN M, Deng S, Cao Y, Huang L, et al
    ASO Author Reflections: Stage II/III Colorectal Cancer Patients with Mismatch Repair Deficiency Need More Personalized Adjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15926.
    >> Share

  271. NEE K, Hosohama L, Alobuia W, Kim AC, et al
    Defining Colorectal Cancer Cells on a Single Cell Level Reveals LGR5+ Proliferative Stem Cell Expression in Peritoneal Metastasis.
    Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15783.
    >> Share

  272. ROXBURGH CS
    Time to Change Strategy in Non-metastatic Locally Advanced Mismatch Repair-Deficient Colon Cancer.
    Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15780.
    >> Share

  273. STEFFENS D, Solomon MJ, Jack S, West MA, et al
    ASO Author Reflections: Improving Postoperative Outcomes in Colorectal Cancer Surgery: Where are We with Prehabilitation?
    Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15835.
    >> Share

  274. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
    ASO Visual Abstract: The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer-A Retrospective Cohort Study.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15747.
    >> Share

  275. CHEN M, Deng S, Cao Y, Wang J, et al
    Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15759.
    >> Share

  276. LIN X, Haiyang Z
    Patient-Reported Outcomes in Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer After Pelvic Exenteration.
    Ann Surg Oncol. 2024 Jul 9. doi: 10.1245/s10434-024-15722.
    >> Share

  277. LIN X, Haiyang Z
    ASO Author Reflections: Pelvic Exenteration for Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer: A Report of 122 Cases.
    Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15782.
    >> Share

  278. AYABE RI, Beaty K, Newhook TE, Cao HST, et al
    Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2024 Jul 6. doi: 10.1245/s10434-024-15694.
    >> Share

  279. JANCZEWSKI LM, Asare EA, Goodman KA
    Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer.
    Ann Surg Oncol. 2024;31:4155-4158.
    >> Share

  280. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
    ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2024;31:4466-4467.
    >> Share

  281. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
    ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
    Ann Surg Oncol. 2024;31:4749-4750.
    >> Share

  282. SHAPERA E, Ross S, Pattilachan T, Christodoulou M, et al
    Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
    Ann Surg Oncol. 2024;31:4449-4451.
    >> Share

  283. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
    Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:4436-4444.
    >> Share

  284. EL ASMAR A, Kamdem L, Khaled C, Liberale G, et al
    ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:4558-4559.
    >> Share

  285. BLANCO ASENSIO N, Aliseda Jover D, Marti-Cruchaga P, Lapuente F, et al
    Anatomical Left Hepatectomy Extended to Caudate Lobe due to Colorectal Metastasis with Intrabiliary Growth: Securing Optimal Margins with a Laennec's Capsule Approach and Vein-Guided Resection.
    Ann Surg Oncol. 2024;31:4447-4448.
    >> Share

  286. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
    Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Ann Surg Oncol. 2024;31:4339-4348.
    >> Share

  287. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
    Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2024;31:4413-4426.
    >> Share

    June 2024
  288. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
    ASO Visual Abstract: Para-aortic Lymph Node Dissection for Colorectal Cancer-Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
    Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15690.
    >> Share

  289. STEFFENS D, Nott F, Koh C, Jiang W, et al
    Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
    Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15593.
    >> Share

  290. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
    The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2024 Jun 21. doi: 10.1245/s10434-024-15595.
    >> Share

  291. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
    Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
    Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15539.
    >> Share

  292. SHIN JK, Kim HC
    ASO Author Reflections: Robotic Surgery is Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy.
    Ann Surg Oncol. 2024;31:3959-3960.
    >> Share

  293. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
    ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:3787-3788.
    >> Share

  294. KAMDEM L, Asmar AE, Demetter P, Zana IC, et al
    Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:3778-3784.
    >> Share

  295. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
    Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
    Ann Surg Oncol. 2024;31:3758-3768.
    >> Share

  296. PIKOULIS E, Beyer K, Kreis ME, Pawlik TM, et al
    ASO Author Reflections: Surgical Technique for Colorectal Liver Metastases: Biology is King, but the Princes and Princesses (Surgical Techniques) also Matter.
    Ann Surg Oncol. 2024;31:4046-4047.
    >> Share

    May 2024
  297. HUANG Y, Liao F, Chen H, Shu X, et al
    ASO Author Reflections: Self-expanding Metal Stents for Right-Sided Colonic Cancer Obstruction.
    Ann Surg Oncol. 2024;31:3242-3243.
    >> Share

  298. GOMAA I, Aboelmaaty S, Narasimhan AL, Bhatt H, et al
    The Impact of Enhanced Recovery on Long-Term Survival in Rectal Cancer.
    Ann Surg Oncol. 2024;31:3233-3241.
    >> Share

  299. ONO Y, Inoue Y, Ito H, Takahashi Y, et al
    ASO Author Reflections: Advancing Two-Stage Hepatectomy: Laparoscopic Portal Vein Ligation and Embolization for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:3114-3115.
    >> Share

  300. HUANG Y, Liao F, Zhan Z, Chen X, et al
    Efficacy and Safety Analysis of Emergency Endoscopic Self-Expanding Metal Stent Placement Without Fluoroscopic Assistance for Right-Sided Colonic Cancer Obstruction.
    Ann Surg Oncol. 2024;31:3212-3221.
    >> Share

  301. GORJI L, Nikahd M, Onuma A, Tsilimigras D, et al
    Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
    Ann Surg Oncol. 2024;31:3389-3396.
    >> Share

  302. SHIN JK, Kim HC, Lee WY, Yun SH, et al
    Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
    Ann Surg Oncol. 2024;31:3203-3211.
    >> Share

  303. FACKCHE NT, Schmocker RK, Nudotor R, Kubi B, et al
    Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
    Ann Surg Oncol. 2024;31:3314-3324.
    >> Share

  304. ONO Y, Inoue Y, Kobayashi K, Sato S, et al
    Laparoscopic Portal Vein Ligation and Embolization During First-Stage Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:3069-3070.
    >> Share

    April 2024
  305. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    Disparities in Colorectal Cancer Screening.
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15296.
    >> Share

  306. BEKKI T, Shimomura M, Yano T, Akabane S, et al
    Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300.
    >> Share

  307. KHAN MMM, Munir MM, Khalil M, Pawlik TM, et al
    Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic.
    Ann Surg Oncol. 2024 Apr 23. doi: 10.1245/s10434-024-15302.
    >> Share

  308. YANG Y, Du Z, Zhang Q
    Letter to Editor regarding article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
    Ann Surg Oncol. 2024 Apr 10. doi: 10.1245/s10434-024-15263.
    >> Share

  309. BOYEV A, Newhook TE
    ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
    Ann Surg Oncol. 2024;31:2600-2601.
    >> Share

  310. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
    ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in Colorectal Liver Metastasis.
    Ann Surg Oncol. 2024;31:2598-2599.
    >> Share

  311. CHOI JS, Kim MJ, Shin R, Park JW, et al
    ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine Tumor 1-2 cm in Size?
    Ann Surg Oncol. 2024;31:2439.
    >> Share

  312. WACH MM, Nunns G, Hamed A, Derby J, et al
    Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:2391-2400.
    >> Share

  313. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2425-2438.
    >> Share

  314. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2606.
    >> Share

  315. SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
    Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the US
    Ann Surg Oncol. 2024;31:2408-2409.
    >> Share

  316. HIRST N, McBride K, Steffens D
    Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
    Ann Surg Oncol. 2024;31:2183-2186.
    >> Share

  317. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2440-2441.
    >> Share

  318. CHOI JS, Kim MJ, Shin R, Park JW, et al
    Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Ann Surg Oncol. 2024;31:2414-2424.
    >> Share

  319. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2547-2556.
    >> Share

  320. CHIU CC
    Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter P
    Ann Surg Oncol. 2024;31:2405-2407.
    >> Share

    March 2024
  321. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
    ASO Visual Abstract: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15140.
    >> Share

    November 2023
  322. SOLBAKKEN AM, Sellevold S, Spasojevic M, Julsrud L, et al
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer.
    Ann Surg Oncol. 2023;30:7602-7611.
    >> Share

  323. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
    Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.
    Ann Surg Oncol. 2023;30:7362-7370.
    >> Share

  324. ZMUC J, Heil J, Herfarth C, Bechstein WO, et al
    Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates.
    Ann Surg Oncol. 2023;30:7624-7632.
    >> Share

  325. WU H, Wang S, Lv H, Lou F, et al
    Effect of Thoracic Epidural Anesthesia on Perioperative Neutrophil Extracellular Trapping Markers in Patients Undergoing Anesthesia and Surgery for Colorectal Cancer: A Randomized, Controlled Trial.
    Ann Surg Oncol. 2023;30:7561-7568.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016